TP53基因突变检测预测Ⅲ期结肠癌患者的无病生存期

    Determination of TP53 Mutation for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage Ⅲ Colon Cancer Patients

    /

    返回文章
    返回